MHT automates behavioral‑health screening

Behavioral-health screening is one of those jobs clinics know they should do more of, but the workflow is ugly. Someone has to send the questionnaire, chase the patient, score it, flag the risky answers, document the result, and then actually route the person to care. Mental Health Technologies is trying to turn that whole chain into software. Its SmarTest AI product sits inside the EMR workflow, sends assessments automatically, writes results back into the chart, and can(mhtech.com)nts. (mhtech.com) ### What is MHT actually selling? Basically, not a new therapy and not a chatbot therapist. SmarTest AI is workflow software for behavioral-health screening. MHT says the system uses appointment-schedule data from the EMR to decide when to send assessments, then drops the completed results directly into the patient chart so staff do not have to re-enter them by hand. (mhtech.com) ### Why does that matter inside a clinic? Because the hard part is usually(mhtech.com) part is the handoff. Clinics already use tools like PHQ-9 and GAD-7, but the process often breaks between “patient answered” and “someone acted on it.” MHT’s pitch is that automation closes that gap — especially when abnormal scores or suicidal-ideation answers need immediate escalation. (mhtech.com) ### How does the referral pie(mhtech.com)AI can send the referral to a behavioral-health partner or another specialty provider. MHT also says practices can set rules for alerts — for example, notifying designated staff when a score crosses a threshold. In one case study, suicidal-ideation responses were redirected to 988, while higher PHQ-9 or GAD-7 scores triggered an offer to connect with a behavioral-health partner. (mhtech.com)ges throughput? MHT’s own case study is the clearest signal. In a pain-management deployment tied to Alliance’s EMR, the company says 76.25% of patients were screened for comorbid behavioral-health concerns from January 1, 2024 to January 1, 2025. It also says nearly 31% of patients asked on the PHQ-9 accepted a behavioral-health referral, and about 29% did on the GAD-7. That is not independent validation, but it does show the kind of operational m(mhtech.com)mhtech.com) ### Where does the money angle come in? This is the part clinics will notice fast. MHT explicitly markets SmarTest AI as a revenue tool as well as a care tool. The company says the platform can help generate revenue through add-on CPT codes and ancillary services, which means screening and referral management are being framed not just as compliance work, but as reimbursable workflow. (mhtech.com) ### Why now? Because more non-psychiatric pra(mhtech.com)reening, but they do not suddenly have extra staff. AdvancedMD’s 2024 integration announcement with MHT made that point pretty plainly: practices want behavioral-health tools that do not pile more admin work onto front-desk and clinical teams. MHT also says its system can integrate with any EMR that has a standard published API, which widens the possible market beyond one EHR vendor. (([mhtech.com)com/company/press-releases/mental-health-technologies-give-practices-more-behavioral-health-tools/)) ### What’s the real takeaway? This is less an AI story than a billing-and-workflow story. The bet is simple — if screening happens automatically inside the chart, more patients get screened, fewer referrals get dropped, and clinics can turn a labor-intensive obligation into a measurable service line. Whether that becomes durable depends on reimbursement, integration quality, and whether providers trust the automation enough to build it into daily care. (mhtech.com)